Search Results - "Liu, Ruonian"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance by Sun, Lei, Wan, Arabella H., Yan, Shijia, Liu, Ruonian, Li, Jiarui, Zhou, Zhuolong, Wu, Ruirui, Chen, Dongshi, Bu, Xianzhang, Ou, Jingxing, Li, Kai, Lu, Xiongbin, Wan, Guohui, Ke, Zunfu

    Published in Acta pharmaceutica Sinica. B (01-01-2024)
    “…Lenvatinib, a second-generation multi-receptor tyrosine kinase inhibitor approved by the FDA for first-line treatment of advanced liver cancer, facing…”
    Get full text
    Journal Article
  2. 2

    Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer by Sun, Lei, Liu, Ruonian, Wu, Zong-Jian, Liu, Zheng-Yu, Wan, Arabella H., Yan, Shijia, Liu, Chuwei, Liang, Heng, Xiao, Min, You, Nan, Lou, Yawen, Deng, Yuan, Bu, Xianzhang, Chen, Dongshi, Huang, Jun, Zhang, Xiaolei, Kuang, Dong-Ming, Wan, Guohui

    Published in Gastroenterology (New York, N.Y. 1943) (01-03-2024)
    “…Although immunotherapy shows substantial advancement in colorectal cancer (CRC) with microsatellite instability high, it has limited efficacy for CRC with…”
    Get full text
    Journal Article